AR-positive TNBC cells treated with Pictilisib dimethanesulfonate for 72 h were significantly more sensitive than the other cell lines, with inhibitory concentrations of 680 nM versus 2044 nM. In OVSAHO cells, treatment at 5 µM in complete medium for 7 days produced a moderate reduction in cell viability. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
AR-positive TNBC cells show greater sensitivity to Pictilisib
Cell-based study · AR + TNBC cells [1]
AR + TNBC cells were significantly more sensitive to GDC-0941 (680 nM versus 2044 nM, P = 0.01) compared to the other cell lines.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 nM-3000 nM
- Exposure duration
- 72 h
- Method
- media containing half-log serial dilutions
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Pictilisib dimethanesulfonate; Compound label in the paper: GDC-0941
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods > Cell proliferation/viability assays and inhibitory concentration of 50% (EC50) determination (S39, S40); Results > LAR TNBC cell lines stimulated by dihydrotestosterone have increased PI3K pathway activity and are sensitive to PI3K/TOR pathway inhibitors (S97); Figure 3 legend (S151)
50% inhibitory concentration (EC50): 50% inhibitory concentration (EC50); comparator: the other cell lines — Results > LAR TNBC cell lines stimulated by dihydrotestosterone have increased PI3K pathway activity and are sensitive to PI3K/TOR pathway inhibitors (S97); Figure 3 legend (S151)
Pictilisib moderately reduces OVSAHO cell viability
Cell-based study · OVSAHO [2]
OVSAHO cells were treated with Pictilisib dimethanesulfonate at 5 µM in complete medium for 7 days. Treatment produced a moderate reduction in cell viability.
Literature-Reported Treatment Conditions
- Treatment concentration
- 5 µM
- Exposure duration
- 7 days
- Method
- in complete medium
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Pictilisib dimethanesulfonate; Compound label in the paper: Pictilisib
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Cell viability assays (S57, S58); Results > PI3K inhibition triggers lethal vacuolization in serum-starved cancer cells with sustained macropinocytosis (S104, S107, S112)
Clonogenic survival: Clonogenic survival; comparator: treated with or without Pictilisib — Results > PI3K inhibition triggers lethal vacuolization in serum-starved cancer cells with sustained macropinocytosis (S104, S107, S112)